Elvitegravir

ATC J05AR09 · 8 markets · 28 records

Elvitegravir 8 markets · 28 records Forms

GB 6 records · 3 strengths

AU 5 records · 2 strengths

  • 150 mgtabletGenvoyaGENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tablets、STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle also in GB·US·CA +1 unknown

Records without a stated strength · 1 Genvoya、Stribild

US 2 records · 1 strengths

CA 2 records · 1 strengths

ES 2 records · 1 strengths

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 Genvoya、Stribild

    TW 1 records · 1 strengths

      Records without a stated strength · 1 Genvoya、捷扶康 膜衣錠

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.